The following license files are associated with this item:
- QMRO Home
- Institute of Dentistry
- Centre for Oral Immunobiology and Regenerative Medicine
- Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans
Browse
Administrators only